Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forodesine in Cutaneous T-Cell Lymphoma
NCT00501735Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Jul 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of forodesine in cutaneous T-cell lymphoma (CTCL), sponsored by BioCryst Pharmaceuticals, Inc.. Started Jul 2007; status: completed.
02
Drugs
forodesine
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00501735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501735.